| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
The BEST place to Learn PLC Programming... Always FREE of course.
Longview Publshng Inc is a New York, NY-based company in the Software and Internet sector.
OppSource is a Saint Paul, MN-based company in the Software and Internet sector.
TouchBistro is the #1 ranked iPad-based point of sale solution specifically designed for restaurants. Restaurants buy TouchBistro because they want a POS that is the easiest to use and learn, increases staff performance, drives greater operation efficiency, brings actionable insights about their business, and improves customer experience. TouchBistro is recognized as the top-grossing app in over 37 countries in the Apple App Store where anyone can try or buy the point of sale.